Christopher J. Kirk insider trades
Open-market stock purchases and sales by Christopher J. Kirk, CEO at Kezar Life Sciences, Inc, from SEC Form 4 filings since Jun 25, 2018.
Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +95%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 11, 2026 | KZR Kezar Life Sciences, Inc | Sold (not open market) | — |
| May 11, 2026 | KZR Kezar Life Sciences, Inc | Sold (not open market) | — |
| May 11, 2026 | KZR Kezar Life Sciences, Inc | Sold (not open market) | — |
| May 11, 2026 | KZR Kezar Life Sciences, Inc | Sold (not open market) | — |
| May 11, 2026 | KZR Kezar Life Sciences, Inc | Sold (not open market) | — |
| May 11, 2026 | KZR Kezar Life Sciences, Inc | Sold (not open market) | — |
| May 11, 2026 | KZR Kezar Life Sciences, Inc | Sold (not open market) | — |
| May 11, 2026 | KZR Kezar Life Sciences, Inc | Sold (not open market) | — |
| May 11, 2026 | KZR Kezar Life Sciences, Inc | Sold (not open market) | — |
| May 11, 2026 | KZR Kezar Life Sciences, Inc | Sold (not open market) | — |
| May 11, 2026 | KZR Kezar Life Sciences, Inc | Sold (not open market) | — |
| May 11, 2026 | KZR Kezar Life Sciences, Inc | Sold (not open market) | — |
Companies traded
- KZR Kezar Life Sciences, Inc: 3 buys, last May 11, 2026
Get free alerts when Christopher J. Kirk files a new trade →